Patents by Inventor Akiko Tasaki
Akiko Tasaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240316250Abstract: A hybrid gel comprising a particulate decellularized tissue (obtained by pulverizing animal-derived biological tissues that are decellularized (decellularized biological tissues)), fibrinogen and thrombin; a cell culture material comprising the hybrid gel; a method for preparing the hybrid gel; and a kit comprising a particulate decellularized tissue and a biological tissue adhesive are provided. The hybrid gel of the present invention exerts the effect to promote differentiation and gain of function of stem cells and the therapeutic effect to a variety of diseases.Type: ApplicationFiled: June 5, 2024Publication date: September 26, 2024Applicants: NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY, SAPPORO MEDICAL UNIVERSITY, ADEKA CORPORATION, KM Biologics Co., Ltd.Inventors: Junichi MATSUDA, Sumika MIYABASHIRA, Satomi HARANO, Akio KISHIDA, Tsuyoshi KIMURA, Jun NEGISHI, Tetsuya HIGAMI, Seiichi FUNAMOTO, Ken-Ichiro HIWATARI, Akiko TASAKI
-
Publication number: 20220323647Abstract: A sheet of biological tissue which includes on at least one side tapered edge portion thinning down in the thickness direction, towards an end thereof, a tubular structure obtained from the sheet, and an artificial blood vessel made up of the tubular structure are provided.Type: ApplicationFiled: June 28, 2022Publication date: October 13, 2022Applicant: ADEKA CORPORATIONInventors: Ken-ichiro HIWATARI, Yu YAMAGUCHI, Takuya KIMURA, Akiko TASAKI
-
Publication number: 20210268113Abstract: The object of the present invention is to provide a technique for promoting membrane permeation of a drug, which is highly versatile and highly safe. The object can be solved by a polymer compound having a molecular weight of 1000 or more, wherein the polymer compound has, at an end of a side chain, one arginine or a basic peptide of chain length of 2 to 6 containing one or more arginine, and comprises a guanidino group of 0.5 to 20 mmol/g, originating from arginine.Type: ApplicationFiled: July 11, 2019Publication date: September 2, 2021Applicants: JOSHO GAKUEN EDUCATIONAL FOUNDATION, ADEKA CORPORATIONInventors: Shinji SAKUMA, Masami UKAWA, Shunsuke TAKAHI, Kazunori FUKUSHIMA, Mio MUTO, Kohei MIYATA, Akiko TASAKI, Hotaru MATSUMOTO
-
Publication number: 20180296728Abstract: A sheet of biological tissue which includes on at least one side tapered edge portion thinning down in the thickness direction, towards an end thereof, a tubular structure obtained from the sheet, and an artificial blood vessel made up of the tubular structure are provided.Type: ApplicationFiled: May 31, 2016Publication date: October 18, 2018Applicant: ADEKA CORPORATIONInventors: Ken-ichiro HIWATARI, Yu YAMAGUCHI, Takuya KIMURA, Akiko TASAKI
-
Patent number: 9583280Abstract: An electricity storage device maintains low internal resistance and high electric capacity. The nonaqueous-electrolytic-solution hybrid electricity storage device employs an anode into/from which lithium can be intercalated and deintercalated and a cathode including activated carbon, even after high-temperature storage and/or high-temperature charging/discharging. Specifically, this electricity storage device includes an anode into/from which lithium can be intercalated and deintercalated, a cathode that includes activated carbon, and a nonaqueous electrolytic solution, wherein the electricity storage device employs a nonaqueous electrolytic solution that includes at least one type of compound represented by one of general formulas (1) to (5). Details on the general formulas (1) to (5) are as described in the Description.Type: GrantFiled: July 12, 2013Date of Patent: February 28, 2017Assignee: ADEKA CORPORATIONInventors: Takayuki Taki, Hiroaki Watanabe, Atsuki Shibuya, Akiko Tasaki, Eiji Katsuno
-
Patent number: 9419306Abstract: The invention provides a nonaqueous electrolyte for batteries and a nonaqueous secondary battery using the same which maintains small internal resistance and high electric capacity in high temperature storage. The nonaqueous electrolyte has an electrolyte salt, a compound of general formula (1), and a compound of general formula (2) dissolved in an organic solvent. The ratio of the compound of formula (2) to the sum of the compound of formula (1) and the compound of formula (2) is 0.1 to 8 mass %. In the formulae, R1, R2, R3, and R4 each independently represent C1-C8 alkyl.Type: GrantFiled: November 1, 2012Date of Patent: August 16, 2016Assignee: ADEKA CORPORATIONInventors: Takayuki Taki, Hiroaki Watanabe, Atsuki Shibuya, Akiko Tasaki
-
Patent number: 9337511Abstract: Disclosed is a nonaqueous secondary battery using a positive electrode containing a transition metal and lithium. The battery is prevented from deterioration due to elution of the transition metal from the positive electrode and thereby capable of maintaining small internal resistance and high electrical capacity even after high temperature storage or high-temperature charge and discharge cycles. The battery includes a negative electrode capable of intercalating and deintercalating lithium, a positive electrode containing a transition metal and lithium, and a nonaqueous electrolyte having a lithium salt dissolved in an organic solvent, the nonaqueous electrolyte containing a polycarboxylic ester compound represented by general formula (1) or (2).Type: GrantFiled: October 31, 2012Date of Patent: May 10, 2016Assignee: ADEKA CORPORATIONInventors: Takayuki Taki, Hiroaki Watanabe, Atsuki Shibuya, Akiko Tasaki, Eiji Katsuno
-
Publication number: 20160058910Abstract: A particulate decellularized tissue is provided which shows sufficiently effective tissue regeneration and does not show cytotoxicity when used as material for cell culture. In accordance with the method for preparing a particulate decellularized tissue comprising a step of applying a high hydrostatic pressure to animal-derived tissues in a medium, a particulate decellularized tissue is obtained which does not show cytotoxicity but shows the effect of cellular attraction and the effect of induction of cellular differentiation and shows a high effect of tissue regeneration.Type: ApplicationFiled: May 2, 2014Publication date: March 3, 2016Applicants: NATIIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY, ADEKA CORPORATIONInventors: Akio KISHIDA, Tsuyoshi KIMURA, Jun NEGISHI, Ken-ichiro HIWATARI, Akiko TASAKI
-
Publication number: 20160051731Abstract: A hybrid gel comprising a particulate decellularized tissue (obtained by pulverizing animal-derived biological tissues that are decellularized (decellularized biological tissues)), fibrinogen and thrombin; a cell culture material comprising the hybrid gel; a method for preparing the hybrid gel; and a kit comprising a particulate decellularized tissue and a biological tissue adhesive are provided. The hybrid gel of the present invention exerts the effect to promote differentiation and gain of function of stem cells and the therapeutic effect to a variety of diseases.Type: ApplicationFiled: May 2, 2014Publication date: February 25, 2016Applicants: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE, NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY, SAPPORO MEDICAL UNIVERSITY, ADEKA CORPORATIONInventors: Junichi MATSUDA, Sumika MIYABASHIRA, Satomi HARANO, Akio KISHIDA, Tsuyoshi KIMURA, Jun NEGISHI, Tetsuya HIGAMI, Seiichi FUNAMOTO, Ken-ichiro HIWATARI, Akiko TASAKI
-
Publication number: 20150206664Abstract: An electricity storage device maintains low internal resistance and high electric capacity. The nonaqueous-electrolytic-solution hybrid electricity storage device employs an anode into/from which lithium can be intercalated and deintercalated and a cathode including activated carbon, even after high-temperature storage and/or high-temperature charging/discharging. Specifically, this electricity storage device includes an anode into/from which lithium can be intercalated and deintercalated, a cathode that includes activated carbon, and a nonaqueous electrolytic solution, wherein the electricity storage device employs a nonaqueous electrolytic solution that includes at least one type of compound represented by one of general formulas (1) to (5). Details on the general formulas (1) to (5) are as described in the Description.Type: ApplicationFiled: July 12, 2013Publication date: July 23, 2015Applicant: ADEKA CORPORATIONInventors: Takayuki Taki, Hiroaki Watanabe, Atsuki Shibuya, Akiko Tasaki, Eiji Katsuno
-
Publication number: 20150044551Abstract: Disclosed is a nonaqueous secondary battery using a positive electrode containing a transition metal and lithium. The battery is prevented from deterioration due to elution of the transition metal from the positive electrode and thereby capable of maintaining small internal resistance and high electrical capacity even after high temperature storage or high-temperature charge and discharge cycles. The battery includes a negative electrode capable of intercalating and deintercalating lithium, a positive electrode containing a transition metal and lithium, and a nonaqueous electrolyte having a lithium salt dissolved in an organic solvent, the nonaqueous electrolyte containing a polycarboxylic ester compound represented by general formula (1) or (2).Type: ApplicationFiled: October 31, 2012Publication date: February 12, 2015Inventors: Takayuki Taki, Hiroaki Watanabe, Atsuki Shibuya, Akiko Tasaki, Eiji Katsuno
-
Publication number: 20140242456Abstract: The invention provides a nonaqueous electrolyte for batteries and a nonaqueous secondary battery using the same which maintains small internal resistance and high electric capacity in high temperature storage. The nonaqueous electrolyte has an electrolyte salt, a compound of general formula (1), and a compound of general formula (2) dissolved in an organic solvent. The ratio of the compound of formula (2) to the sum of the compound of formula (1) and the compound of formula (2) is 0.1 to 8 mass %. In the formulae, R1, R2, R3, and R4 each independently represent C1-C8 alkyl.Type: ApplicationFiled: November 1, 2012Publication date: August 28, 2014Inventors: Takayuki Taki, Hiroaki Watanabe, Atsuki Shibuya, Akiko Tasaki